Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
28.57
-0.04 (-0.14%)
At close: Apr 17, 2024, 4:00 PM
27.77
-0.80 (-2.80%)
After-hours: Apr 17, 2024, 7:23 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $1.63 billion as of April 17, 2024. Its market cap has increased by 110.53% in one year.
Market Cap
1.63B
Enterprise Value
1.41B
1-Year Change
110.53%
Ranking
Category
Stock Price
$28.57
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.50M to $1.63B, an increase of 338.31%. That is a compound annual growth rate of 31.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 1.65B | -2.15% |
Apr 15, 2024 | 1.69B | -4.70% |
Apr 12, 2024 | 1.77B | -6.12% |
Apr 11, 2024 | 1.89B | 2.57% |
Apr 10, 2024 | 1.84B | -5.54% |
Apr 9, 2024 | 1.95B | 2.30% |
Apr 8, 2024 | 1.91B | 1.11% |
Apr 5, 2024 | 1.89B | 1.97% |
Apr 4, 2024 | 1.85B | -4.08% |
Apr 3, 2024 | 1.93B | 1.28% |
Apr 2, 2024 | 1.90B | -4.33% |
Apr 1, 2024 | 1.99B | 0.29% |
Mar 28, 2024 | 1.98B | -0.50% |
Mar 27, 2024 | 1.99B | 2.16% |
Mar 26, 2024 | 1.95B | -1.40% |
Mar 25, 2024 | 1.98B | -1.07% |
Mar 22, 2024 | 2.00B | -3.97% |
Mar 21, 2024 | 2.08B | 1.75% |
Mar 20, 2024 | 2.05B | 4.73% |
Mar 19, 2024 | 1.95B | -0.06% |
Mar 18, 2024 | 1.96B | 0.57% |
Mar 15, 2024 | 1.95B | -2.66% |
Mar 14, 2024 | 2.00B | -2.76% |
Mar 13, 2024 | 2.05B | 2.13% |
Mar 12, 2024 | 2.01B | -5.59% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UFP Technologies | 1.75B |
Myriad Genetics | 1.72B |
Amneal Pharmaceuticals | 1.71B |
Recursion Pharmaceuticals | 1.68B |
Harmony Biosciences Holdings | 1.68B |
Inhibrx | 1.65B |
Supernus Pharmaceuticals | 1.64B |
Agios Pharmaceuticals | 1.63B |